Home › Targets › MT2

MT2 (2 companies · 6 programs)

Companies with an active program directed at MT2.

Vanda Pharmaceuticals Inc. VNDA

  • HETLIOZ — Non-24-Hour Sleep-Wake Disorder Approved
  • HETLIOZ — Smith-Magenis Syndrome Approved
  • HETLIOZ — Jet Lag Disorder NDA Submitted
  • HETLIOZ — Insomnia NDA Submitted
  • HETLIOZ — Delayed Sleep Phase Disorder Phase 3